Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada

Core Viewpoint - Oncolytics Biotech Inc. has filed an amended registration statement on Form F-4 with the SEC, which includes a management circular/prospectus and other relevant documents related to various proposals [1] Group 1 - The registration statement has been declared effective by the SEC [1]